These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 11331396
1. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. Merkler D, Metz GA, Raineteau O, Dietz V, Schwab ME, Fouad K. J Neurosci; 2001 May 15; 21(10):3665-73. PubMed ID: 11331396 [Abstract] [Full Text] [Related]
7. Intrathecally infused antibodies against Nogo-A penetrate the CNS and downregulate the endogenous neurite growth inhibitor Nogo-A. Weinmann O, Schnell L, Ghosh A, Montani L, Wiessner C, Wannier T, Rouiller E, Mir A, Schwab ME. Mol Cell Neurosci; 2006 May 15; 32(1-2):161-73. PubMed ID: 16697217 [Abstract] [Full Text] [Related]
8. Sequential therapy of anti-Nogo-A antibody treatment and treadmill training leads to cumulative improvements after spinal cord injury in rats. Chen K, Marsh BC, Cowan M, Al'Joboori YD, Gigout S, Smith CC, Messenger N, Gamper N, Schwab ME, Ichiyama RM. Exp Neurol; 2017 Jun 15; 292():135-144. PubMed ID: 28341461 [Abstract] [Full Text] [Related]
9. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. Li S, Strittmatter SM. J Neurosci; 2003 May 15; 23(10):4219-27. PubMed ID: 12764110 [Abstract] [Full Text] [Related]
15. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. Li S, Liu BP, Budel S, Li M, Ji B, Walus L, Li W, Jirik A, Rabacchi S, Choi E, Worley D, Sah DW, Pepinsky B, Lee D, Relton J, Strittmatter SM. J Neurosci; 2004 Nov 17; 24(46):10511-20. PubMed ID: 15548666 [Abstract] [Full Text] [Related]